PortViewPortView
Natus Medical logo

Natus Medical (NTUS) Stock Analysis

NASDAQHealthcareMedical - Devices

$32.96+0.00%
1-year price historyRange $21.99 – $33.51
52-week range$32.96
$20.90$33.93

What Natus Medical does

Natus Medical Incorporated is a global provider of advanced medical device solutions, dedicated to the diagnosis and treatment of conditions affecting the central nervous and sensory systems. The company's offerings are utilized for the screening, detection, therapeutic intervention, ongoing monitoring, and tracking of a wide array of prevalent medical issues. Its product portfolio addresses critical areas such as newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disturbances, and neuromuscular diseases. Natus develops sophisticated computerized neurodiagnostic systems for specialties including audiology, neurology, polysomnography, and neonatology. Furthermore, it supplies software systems designed for the management and tracking of disorders within public health laboratories. Specific solutions encompass electroencephalography (EEG), long-term monitoring, intensive care unit monitoring, electromyography (EMG), comprehensive sleep analysis (polysomnography), and intra-operative monitoring. The company also furnishes products for hearing assessment, screening initiatives, and precision instrument fitting. Additional specialized offerings include jaundice management tools, devices for brain injury, and cutting-edge eye imaging systems specifically engineered for neonatal and pediatric retinal examination. Moreover, Natus provides essential equipment for the daily operations of neonatal intensive care units (NICUs), systems for evaluating balance disorders, and NICVIEW, an innovative live video streaming service that connects families with their infants in the NICU. It also offers computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. The company's diverse clientele includes university medical centers, both public and private hospitals, private physician practices, clinics, and research laboratories worldwide. Established in 1987, the organization was initially known as ALGOTEK Instruments, Inc., before officially changing its name to Natus Medical Incorporated in September 1988. Its corporate headquarters are situated in Middleton, Wisconsin.

Key metrics

Market cap
$0
P/E (TTM)
86.74
EPS (TTM)
$0.38
Beta
0.23
Dividend yield
0.00%
Revenue / share
$13.94
50-day avg
$32.61
200-day avg
$27.38
52-week high
$33.93
52-week low
$20.90
CEO
Jonathan Kennedy

ETFs linked to NTUS

Broad-market and Healthcare sector ETFs an investor holding Natus Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NTUS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NTUS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Natus Medical?
Natus Medical trades under the ticker NTUS on NASDAQ.
Which exchange is NTUS listed on?
NTUS is listed on NASDAQ.
What sector does Natus Medical operate in?
Natus Medical is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze NTUS in a portfolio?
PortView shows NTUS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.